The Young Investigator Award 2004

The Young Investigator Awards are given to recipients who have submitted abstracts to the International Congress of The Transplantation Society and received the highest scores from an international panel of reviewers. The award has been made possible by the generous support of Astellas Pharma Inc.

Koji Yazawa, BOSTON, MA , UNITED STATES

NEITHER COMPLEMENT INHIBITION NOR DEPLETION OF NATURAL ANTIBODY IS REQUIRED TO AVOID HYPERACUTE OR ACCELERATED ACUTE REJECTION FOLLOW-ING GALT-KO PIG-TO-BABOON RENAL TRANSPLANTATION

Tun Jie, MINNEAPOLIS, UNITED STATES

PANCREATIC ISLET XENOTRANSPLANTS RESTORE NORMOGLYCEMIA AND INSULIN INDEPENDENCE IN IMMUNOSUPPRESSED NON-HUMAN PRIMATES

Svjetlan Boskovic, BOSTON, MA, UNITED STATES

LONG TERM (>5 YEARS) OBSERVATIONS IN RENAL ALLOGRAFT RECIPIENTS TREATED WITH CHIMERISM-INDUCING NONMYELOABLATIVE REGIMEN WITH CD154 BLOCKADE

Michelle Solomon, LA JOLLA, UNITED STATES

CONSTITUTIVE EXPRESSION OF SUPPRESSOR OF CYTOKINE SIGNALING-1 (SOCS-1) IN PANCREATIC ISLETS DELAYS ISLET ALLOGRAFT REJECTION

Mona Doshi, IOWA CITY, IA, UNITED STATES

SHORT AND LONG TERM OUTCOME OF LIVER TRANSPLANTS FROM DONORS DECEASED AFTER CARDIAC DEATH (DCD)

Angela Webster, WESTMEAD, NSW, AUSTRALIA

INCIDENCE, RISK AND PREDICTORS OF CANCER AFTER RENAL TRANSPLANTATION; ANANALYSIS OF ANZDATA, THE AUSTRALIA AND NEW ZEALAND DIALYSIS AND TRANSPLANT REGISTRY

Maren Ruhnke, KIEL, GERMANY

NORMALIZATION OF BLOOD GLUCOSE BY HUMAN MONOCYTE-DERIVED PANCREATIC ISLET-LIKE||CELLS IN STREPTOZOTOZIN DIABETIC MICE||-PERSPECTIVES FOR AUTOLOGOUS CELL THERAPY

Hao Wang, LONDON, CANADA

INHIBITION OF TERMINAL COMPLEMENT WITH A FUNCTIONALLY BLOCKING ANTI-C5 MONOCLONAL ANTIBODY PREVENTS ACUTE HUMORAL REJECTION AND ACCELERATED HUMORAL REJECTION IN A MOUSE CARDIAC ALLOGRAFT TRANSPLANTATION MODEL

Constantino Fondevila, LOS ANGELES, UNITED STATES

CYCLIC RGD PEPTIDES WITH HIGH AFFINITY FOR ALPHA5BETA1 INTEGRIN INHIBIT MACROPHAGE RECRUITMENT IN STEATOTIC LIVER ISCHEMIA/REPERFUSION INJURY

Robert Öllinger, INNSBRUCK, AUSTRIA

BILIRUBIN SUPPRESSES NEOINTIMA FORMATION BY INTERACTING WITH THE RETINOBLASTOMA TUMOR SUPPRESSOR PROTEIN PATHWAY

Cecile Braudeau, NANTES, FRANCE

BLOOD CD25+CD4+ T CELLS PHENOTYPE AND REGULATION ASSOCIATED MOLECULES IN "OPERATIONALLY TOLERANT” VERSUS CHRONIC REJECTION HUMAN KIDNEY RECIPIENTS

Supported through an unrestricted educational grand from: Astellas

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi